Cost-effectiveness analysis of denosumab versus alendronate for improving bone mineral density in renal transplant recipients: a comparative study

Cost-effectiveness analysis of denosumab versus alendronate for improving bone mineral density in renal transplant recipients: a comparative study

Abstract Background Denosumab and alendronate had a positive impact on bone mineral density (BMD) preservation after kidney transplantation. However, the cost-effectiveness of these agents in the context of kidney transplantation remains largely unexplored. We have conducted a cost-effectiveness ana...

Full description

Bibliographic Details
Main Authors: Mona Alshahawey, May A Shawki, Sherihan Ahmed Sayed, Ahmad Elseasi, Lamia ElWakeel
Format: Article
Language:English
Published: SpringerOpen 2024-10-01
Series:Future Journal of Pharmaceutical Sciences
Subjects:
Decision analysis
Alendronate
Denosumab
Compliance
Fracture
BMD
Online Access:https://doi.org/10.1186/s43094-024-00719-w

Internet

https://doi.org/10.1186/s43094-024-00719-w

Similar Items